Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
MPM BioVentures 2014, L.P.
9 Sep 2026
10% owner
Sell indirect
28,837
$7.13
$205.61K
Mpm Bioventures 2018, L.p.
9 Sep 2026
10% owner
Sell indirect
28,837
$7.13
$205.61K
MPM BioVentures 2014, L.P.
8 Sep 2026
10% owner
Sell indirect
192,500
$7.41
$1.43M
Mpm Bioventures 2018, L.p.
8 Sep 2026
10% owner
Sell indirect
192,500
$7.41
$1.43M
MPM BioVentures 2014, L.P.
4 Sep 2026
10% owner
Sell indirect
38,500
$7.11
$273.74K
Mpm Bioventures 2018, L.p.
4 Sep 2026
10% owner
Sell indirect
38,500
$7.11
$273.74K
MPM BioVentures 2014, L.P.
3 Sep 2026
10% owner
Sell indirect
32,263
$7.17
$231.33K
Mpm Bioventures 2018, L.p.
3 Sep 2026
10% owner
Sell indirect
32,263
$7.17
$231.33K
MPM BioVentures 2014, L.P.
2 Sep 2026
10% owner
Sell indirect
25,131
$7.19
$180.69K
Mpm Bioventures 2018, L.p.
2 Sep 2026
10% owner
Sell indirect
25,131
$7.19
$180.69K
MPM BioVentures 2014, L.P.
1 Sep 2026
10% owner
Sell indirect
29,088
$7.06
$205.36K
Mpm Bioventures 2018, L.p.
1 Sep 2026
10% owner
Sell indirect
29,088
$7.06
$205.36K
MPM BioVentures 2014, L.P.
31 Aug 2026
10% owner
Sell indirect
44,259
$6.99
$309.37K
Mpm Bioventures 2018, L.p.
31 Aug 2026
10% owner
Sell indirect
44,259
$6.99
$309.37K
MPM BioVentures 2014, L.P.
28 Aug 2026
10% owner
Sell indirect
3,733
$7.01
$26.17K
Mpm Bioventures 2018, L.p.
28 Aug 2026
10% owner
Sell indirect
3,733
$7.01
$26.17K
MPM BioVentures 2014, L.P.
27 Aug 2026
10% owner
Sell indirect
38,922
$7.20
$280.24K
Mpm Bioventures 2018, L.p.
27 Aug 2026
10% owner
Sell indirect
38,922
$7.20
$280.24K
Mpm Bioventures 2018, L.p.
26 Aug 2026
10% owner
Sell indirect
14,569
$7.06
$102.86K
MPM BioVentures 2014, L.P.
26 Aug 2026
10% owner
Sell indirect
14,569
$7.06
$102.86K
Mpm Bioventures 2018, L.p.
25 Aug 2026
10% owner
Sell indirect
26,522
$7.54
$199.98K
MPM BioVentures 2014, L.P.
25 Aug 2026
10% owner
Sell indirect
26,522
$7.54
$199.98K
Mpm Bioventures 2018, L.p.
24 Aug 2026
10% owner
Sell indirect
21,623
$7.34
$158.71K
MPM BioVentures 2014, L.P.
24 Aug 2026
10% owner
Sell indirect
21,623
$7.34
$158.71K
Kush Parmar
10 Aug 2026
Director
Sell indirect
92,444
$7.00
$647.11K
5AM Ventures V, L.P.
7 Aug 2026
10% owner
Sell
52,317
$6.85
$358.37K
Kush Parmar
7 Aug 2026
Director
Sell indirect
52,317
$6.85
$358.37K
5AM Ventures V, L.P.
6 Aug 2026
10% owner
Sell
10,494
$7.00
$73.46K
Kush Parmar
6 Aug 2026
Director
Sell indirect
10,494
$7.00
$73.46K
Kush Parmar
31 Jul 2026
Director
Sell indirect
1,718
$6.85
$11.77K
5AM Ventures V, L.P.
31 Jul 2026
10% owner
Sell
1,718
$6.85
$11.77K
Kush Parmar
30 Jul 2026
Director
Sell indirect
114,756
$6.93
$795.26K
5AM Ventures V, L.P.
30 Jul 2026
10% owner
Sell
114,756
$6.93
$795.26K
Bernhardt G Zeiher
20 May 2026
Director
Buy indirect
5,000
$5.86
$29.32K
Nathan J Dowden
4 May 2026
President & COO
Sold after exercise
15,000
$15.33
$229.95K
Natarajan Sethuraman
4 May 2026
President, Research & Develop.
Sold on a plan
25,907
$15.39
$398.81K
Kory James Wentworth
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,500
$12.95
$32.38K
Kory James Wentworth
10 Mar 2026
Chief Financial Officer
Sold on a plan
11,388
$13.02
$148.22K
Nathan J Dowden
10 Mar 2026
President & COO
Sold on a plan
11,894
$13.05
$155.19K
Kory James Wentworth
9 Mar 2026
Chief Financial Officer
Sold on a plan
5,089
$13.00
$66.16K
Nathan J Dowden
9 Mar 2026
President & COO
Sold on a plan
3,116
$13.02
$40.58K
Kory James Wentworth
4 Mar 2026
Chief Financial Officer
Sold on a plan
7,988
$12.25
$97.89K
Kory James Wentworth
21 Nov 2025
Chief Financial Officer
Sold on a plan
8,910
$9.98
$88.93K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
13,082
$9.07
$118.69K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
1,186
$9.07
$10.76K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
13,386
$9.07
$121.39K
Baker Bros. Advisors LP
20 Nov 2025
10% owner
Buy indirect
1,213
$9.07
$11.00K
5AM Ventures V, L.P.
14 Nov 2025
10% owner
Sell
200,000
$8.80
$1.76M
Kush Parmar
14 Nov 2025
Director
Sell indirect
200,000
$8.80
$1.76M
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
11,494
$7.95
$91.43K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
1,040
$7.95
$8.27K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
80,881
$7.73
$625.33K
Baker Bros. Advisors LP
12 Nov 2025
10% owner
Buy indirect
7,321
$7.73
$56.60K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
30,879
$7.54
$232.81K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
2,795
$7.54
$21.07K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
11,701
$7.39
$86.48K
Baker Bros. Advisors LP
11 Nov 2025
10% owner
Buy indirect
1,059
$7.39
$7.83K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
2,947
$7.22
$21.29K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
267
$7.22
$1.93K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
25,364
$7.21
$182.97K
Baker Bros. Advisors LP
10 Nov 2025
10% owner
Buy indirect
2,296
$7.21
$16.56K
5AM Ventures V, L.P.
9 Jul 2025
10% owner
Sell indirect
6,935
$7.50
$52.03K
5AM Ventures V, L.P.
9 Jul 2025
10% owner
Sell
20,065
$7.50
$150.53K
Kush Parmar
9 Jul 2025
Director
Sell indirect
6,935
$7.50
$52.03K
Kush Parmar
9 Jul 2025
Director
Sell indirect
20,065
$7.50
$150.53K
5AM Ventures V, L.P.
1 Jul 2025
10% owner
Sell indirect
6,422
$7.12
$45.74K
5AM Ventures V, L.P.
1 Jul 2025
10% owner
Sell
18,578
$7.12
$132.32K
Kush Parmar
1 Jul 2025
Director
Sell indirect
6,422
$7.12
$45.74K
Kush Parmar
1 Jul 2025
Director
Sell indirect
18,578
$7.12
$132.32K
5AM Ventures V, L.P.
30 Jun 2025
10% owner
Sell indirect
6,422
$6.81
$43.75K
5AM Ventures V, L.P.
30 Jun 2025
10% owner
Sell
18,578
$6.81
$126.57K
Kush Parmar
30 Jun 2025
Director
Sell indirect
6,422
$6.81
$43.75K
Kush Parmar
30 Jun 2025
Director
Sell indirect
18,578
$6.81
$126.57K
5AM Ventures V, L.P.
27 Jun 2025
10% owner
Sell indirect
19,265
$6.91
$133.12K
5AM Ventures V, L.P.
27 Jun 2025
10% owner
Sell
55,735
$6.91
$385.13K
Kush Parmar
27 Jun 2025
Director
Sell indirect
19,265
$6.91
$133.12K
Kush Parmar
27 Jun 2025
Director
Sell indirect
55,735
$6.91
$385.13K
Kory James Wentworth
3 Apr 2025
Chief Financial Officer
Exercised, kept
11,134
$2.10
$23.38K
Kory James Wentworth
17 Mar 2025
Chief Financial Officer
Sold on a plan
1,784
$10.67
$19.04K
MPM BioVentures 2014, L.P.
11 Dec 2024
10% owner
Sell indirect
21,787
$20.23
$440.75K
Mpm Bioventures 2018, L.p.
11 Dec 2024
10% owner
Sell indirect
21,787
$20.23
$440.75K
MPM BioVentures 2014, L.P.
10 Dec 2024
10% owner
Sell indirect
22,935
$20.77
$476.36K
Mpm Bioventures 2018, L.p.
10 Dec 2024
10% owner
Sell indirect
22,935
$20.77
$476.36K
Natarajan Sethuraman
3 Dec 2024
President, Research & Develop.
Sold on a plan
11,703
$20.15
$235.79K
Natarajan Sethuraman
2 Dec 2024
President, Research & Develop.
Sold on a plan
4,088
$20.26
$82.83K
Kory James Wentworth
2 Dec 2024
Chief Financial Officer
Sold after exercise
5,000
$20.00
$99.98K
Natarajan Sethuraman
29 Nov 2024
President, Research & Develop.
Sold on a plan
100
$20.00
$2.00K
Kory James Wentworth
29 Nov 2024
Chief Financial Officer
Sold after exercise
1,000
$19.97
$19.97K
Natarajan Sethuraman
13 Nov 2024
President, Research & Develop.
Sold on a plan
2,700
$20.04
$54.11K
Kory James Wentworth
11 Nov 2024
Chief Financial Officer
Sold after exercise
8,637
$19.98
$172.56K
Natarajan Sethuraman
11 Nov 2024
President, Research & Develop.
Sold on a plan
1,409
$20.01
$28.19K
Natarajan Sethuraman
6 Nov 2024
President, Research & Develop.
Sold on a plan
2,745
$19.32
$53.02K
Natarajan Sethuraman
6 Nov 2024
President, Research & Develop.
Sold on a plan
9,554
$18.71
$178.75K
Natarajan Sethuraman
5 Nov 2024
President, Research & Develop.
Sold on a plan
5,171
$18.18
$94.01K
Natarajan Sethuraman
4 Nov 2024
President, Research & Develop.
Sold on a plan
749
$18.02
$13.50K
Natarajan Sethuraman
16 Oct 2024
President, Research & Develop.
Sold on a plan
600
$18.00
$10.80K
Nathan J Dowden
26 Sep 2024
President & COO
Sold on a plan
847
$16.00
$13.55K
Natarajan Sethuraman
9 Sep 2024
Chief Scientific Officer
Sold on a plan
2,642
$15.09
$39.86K
Nathan J Dowden
9 Sep 2024
President & COO
Sold on a plan
1,904
$15.07
$28.69K
Kory James Wentworth
9 Sep 2024
Chief Financial Officer
Sold on a plan
3,195
$14.97
$47.83K
Natarajan Sethuraman
6 Sep 2024
Chief Scientific Officer
Sold on a plan
600
$15.24
$9.14K
Nathan J Dowden
6 Sep 2024
President & COO
Sold on a plan
399
$15.19
$6.06K
Nathan J Dowden
16 Aug 2024
President & COO
Sold after exercise
502
$16.70
$8.38K
Nathan J Dowden
16 Aug 2024
President & COO
Sold after exercise
26,595
$16.26
$432.42K
Dipal Doshi
15 Jul 2024
CEO
Sold on a plan
1,600
$17.81
$28.50K
Natarajan Sethuraman
15 Jul 2024
Chief Scientific Officer
Sold on a plan
638
$18.00
$11.48K
Dipal Doshi
12 Jul 2024
CEO
Sold on a plan
300
$18.00
$5.40K
Natarajan Sethuraman
12 Jul 2024
Chief Scientific Officer
Sold on a plan
600
$18.00
$10.80K
Kory James Wentworth
8 Jul 2024
Chief Financial Officer
Sold on a plan
1,758
$14.95
$26.28K
Dipal Doshi
13 Jun 2024
CEO
Sold on a plan
1,000
$16.17
$16.17K
Peter S Kim
3 Jun 2024
Director
Exercised, kept
11,918
$6.06
$72.22K
Natarajan Sethuraman
20 May 2024
Chief Scientific Officer
Sold on a plan
9,675
$15.19
$146.94K
Dipal Doshi
17 May 2024
CEO
Sold on a plan
1,200
$15.11
$18.13K
Natarajan Sethuraman
17 May 2024
Chief Scientific Officer
Sold on a plan
8,305
$15.14
$125.75K
Dipal Doshi
16 May 2024
CEO
Sold on a plan
1,800
$15.00
$27.00K
Natarajan Sethuraman
16 May 2024
Chief Scientific Officer
Sold on a plan
1,000
$15.00
$15.00K
Peter S Kim
14 May 2024
Director
Buy
25,000
$14.59
$364.67K
Peter S Kim
9 May 2024
Director
Buy
2,200
$14.25
$31.34K
Peter S Kim
8 May 2024
Director
Buy
2,276
$14.04
$31.96K
Peter S Kim
8 Apr 2024
Director
Buy
2,600
$13.57
$35.29K
Peter S Kim
28 Mar 2024
Director
Buy
1,512
$13.75
$20.79K
Peter S Kim
26 Mar 2024
Director
Buy
2,750
$13.64
$37.51K
Peter S Kim
25 Mar 2024
Director
Buy
3,180
$13.36
$42.47K
Peter S Kim
22 Mar 2024
Director
Buy
3,118
$13.76
$42.90K
Peter S Kim
21 Mar 2024
Director
Buy
704
$13.24
$9.32K
Peter S Kim
20 Mar 2024
Director
Buy
1,128
$12.66
$14.28K
Peter S Kim
19 Mar 2024
Director
Buy
900
$12.66
$11.40K
Kory James Wentworth
15 Mar 2024
Chief Financial Officer
Exercised, kept
9,000
$2.10
$18.90K
Nathan J Dowden
6 Mar 2024
President & COO
Sold on a plan
1,826
$12.32
$22.50K
Kory James Wentworth
6 Mar 2024
Chief Financial Officer
Sold on a plan
4,086
$12.31
$50.29K
Dipal Doshi
15 Feb 2024
CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
16 Jan 2024
CEO
Sold on a plan
1,000
$15.99
$15.99K
Kory James Wentworth
26 Dec 2023
Chief Financial Officer
Sold after exercise
94
$16.67
$1.57K
Kory James Wentworth
22 Dec 2023
Chief Financial Officer
Sold after exercise
3,677
$16.48
$60.61K
Kory James Wentworth
22 Dec 2023
Chief Financial Officer
Sold after exercise
6,529
$15.24
$99.51K
Kory James Wentworth
21 Dec 2023
Chief Financial Officer
Sold after exercise
2,200
$15.07
$33.15K
Dipal Doshi
20 Dec 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
13 Nov 2023
President and CEO
Sold on a plan
1,000
$16.23
$16.23K
Dipal Doshi
17 Oct 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
13 Sep 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Nathan J Dowden
6 Sep 2023
Chief Operating Officer
Sold on a plan
59
$14.01
$826.41
Nathan J Dowden
6 Sep 2023
Chief Operating Officer
Sold on a plan
913
$13.43
$12.26K
Nerissa Kreher
6 Sep 2023
Chief Medical Officer
Sold on a plan
21
$14.00
$294.00
Nerissa Kreher
6 Sep 2023
Chief Medical Officer
Sold on a plan
871
$13.46
$11.73K
Kory James Wentworth
6 Sep 2023
Chief Financial Officer
Sold on a plan
46
$14.03
$645.38
Kory James Wentworth
6 Sep 2023
Chief Financial Officer
Sold on a plan
904
$13.45
$12.16K
Dipal Doshi
14 Aug 2023
President and CEO
Sold on a plan
1,000
$15.67
$15.67K
Nerissa Kreher
4 Aug 2023
Chief Medical Officer
Sold after exercise
6,898
$14.14
$97.52K
Nerissa Kreher
3 Aug 2023
Chief Medical Officer
Sold after exercise
9,464
$14.74
$139.53K
Nerissa Kreher
2 Aug 2023
Chief Medical Officer
Sold after exercise
68
$16.82
$1.14K
Nerissa Kreher
2 Aug 2023
Chief Medical Officer
Sold after exercise
1,000
$16.01
$16.01K
Nerissa Kreher
2 Aug 2023
Chief Medical Officer
Sold after exercise
9,280
$15.09
$140.01K
Natarajan Sethuraman
11 Jul 2023
Chief Scientific Officer
Sold on a plan
14,852
$18.04
$267.92K
Nathan J Dowden
11 Jul 2023
Chief Operating Officer
Sold on a plan
3,897
$18.05
$70.33K
Kory James Wentworth
11 Jul 2023
Chief Financial Officer
Sold after exercise
3,884
$18.00
$69.90K
Natarajan Sethuraman
10 Jul 2023
Chief Scientific Officer
Sold on a plan
3,026
$18.00
$54.47K
Nathan J Dowden
10 Jul 2023
Chief Operating Officer
Sold on a plan
3,200
$18.00
$57.61K
Kory James Wentworth
10 Jul 2023
Chief Financial Officer
Sold after exercise
6,116
$17.98
$109.96K
Kory James Wentworth
29 Jun 2023
Chief Financial Officer
Exercised, kept
8,790
$2.10
$18.46K
Nathan J Dowden
22 Jun 2023
Chief Operating Officer
Sold on a plan
7,097
$16.02
$113.70K
Kory James Wentworth
21 Jun 2023
Chief Financial Officer
Sold after exercise
8,907
$15.17
$135.13K
Kory James Wentworth
21 Jun 2023
Chief Financial Officer
Sold after exercise
8,593
$14.84
$127.52K
Nathan J Dowden
20 Jun 2023
Chief Operating Officer
Sold on a plan
8,885
$14.94
$132.70K
Dipal Doshi
27 Apr 2023
President and CEO
Sold on a plan
2,000
$13.71
$27.42K
Natarajan Sethuraman
17 Apr 2023
Chief Scientific Officer
Sold on a plan
3,961
$18.00
$71.32K
Dipal Doshi
17 Apr 2023
President and CEO
Sold on a plan
2,092
$18.01
$37.68K
Dipal Doshi
27 Mar 2023
President and CEO
Sold on a plan
200
$15.51
$3.10K
Dipal Doshi
27 Mar 2023
President and CEO
Sold on a plan
1,800
$14.63
$26.33K
Nerissa Kreher
2 Mar 2023
Chief Medical Officer
Sell
164
$11.22
$1.84K
Nerissa Kreher
2 Mar 2023
Chief Medical Officer
Sell
1,477
$10.49
$15.50K
Kory James Wentworth
2 Mar 2023
Chief Financial Officer
Sell
145
$11.23
$1.63K
Kory James Wentworth
2 Mar 2023
Chief Financial Officer
Sell
1,602
$10.46
$16.76K
Dipal Doshi
28 Feb 2023
President and CEO
Sell
2,000
$12.00
$24.00K
Dipal Doshi
27 Jan 2023
President and CEO
Sell
2,000
$12.00
$24.00K
Dipal Doshi
9 Jan 2023
President and CEO
Sell
2,410
$15.02
$36.20K
Nerissa Kreher
30 Dec 2022
Chief Medical Officer
Sell
5,200
$13.45
$69.93K
Dipal Doshi
29 Dec 2022
President and CEO
Sell
400
$15.01
$6.01K
Dipal Doshi
28 Dec 2022
President and CEO
Sell
4,521
$15.01
$67.85K
Dipal Doshi
27 Dec 2022
President and CEO
Sell
9,069
$15.04
$136.38K
Dipal Doshi
27 Dec 2022
President and CEO
Sell
600
$14.80
$8.88K
Kory James Wentworth
8 Dec 2022
Chief Financial Officer
Sold after exercise
4,550
$18.95
$86.24K
Kory James Wentworth
5 Dec 2022
Chief Financial Officer
Sold after exercise
200
$18.05
$3.61K
Kory James Wentworth
2 Dec 2022
Chief Financial Officer
Sold after exercise
2,910
$18.20
$52.95K
Dipal Doshi
28 Nov 2022
President and CEO
Sell
2,000
$13.91
$27.83K
Kory James Wentworth
16 Nov 2022
Chief Financial Officer
Sold after exercise
200
$18.10
$3.62K
Nathan J Dowden
31 Oct 2022
Chief Operating Officer
Sell
2,100
$24.05
$50.50K
Dipal Doshi
27 Oct 2022
President and CEO
Sell
2,000
$21.66
$43.33K
Nerissa Kreher
26 Oct 2022
Chief Medical Officer
Sold after exercise
4,317
$22.01
$95.02K
Nerissa Kreher
26 Oct 2022
Chief Medical Officer
Sold after exercise
643
$21.21
$13.64K
Dipal Doshi
25 Oct 2022
President and CEO
Sell
1,500
$21.50
$32.25K
Dipal Doshi
25 Oct 2022
President and CEO
Sell
7,506
$20.76
$155.81K
Dipal Doshi
25 Oct 2022
President and CEO
Sell
3,055
$20.01
$61.13K
Nathan J Dowden
25 Oct 2022
Chief Operating Officer
Sell
900
$21.85
$19.67K
Nathan J Dowden
25 Oct 2022
Chief Operating Officer
Sell
5,414
$20.97
$113.53K
Nathan J Dowden
25 Oct 2022
Chief Operating Officer
Sell
3,034
$20.10
$61.00K
Nerissa Kreher
25 Oct 2022
Chief Medical Officer
Sold after exercise
100
$22.13
$2.21K
Nerissa Kreher
25 Oct 2022
Chief Medical Officer
Sold after exercise
2,998
$21.42
$64.22K
Nerissa Kreher
25 Oct 2022
Chief Medical Officer
Sold after exercise
4,942
$20.53
$101.46K
Dipal Doshi
24 Oct 2022
President and CEO
Sell
1,241
$19.65
$24.38K
Dipal Doshi
24 Oct 2022
President and CEO
Sell
1,101
$18.90
$20.81K
Nathan J Dowden
24 Oct 2022
Chief Operating Officer
Sell
1,302
$19.66
$25.60K
Nathan J Dowden
24 Oct 2022
Chief Operating Officer
Sell
1,102
$18.88
$20.81K
Dipal Doshi
21 Oct 2022
President and CEO
Sell
2,786
$18.28
$50.92K
Nathan J Dowden
21 Oct 2022
Chief Operating Officer
Sell
2,771
$18.29
$50.67K
Dipal Doshi
20 Oct 2022
President and CEO
Sell
811
$18.01
$14.61K
Nathan J Dowden
20 Oct 2022
Chief Operating Officer
Sell
905
$18.07
$16.36K
Nerissa Kreher
28 Sep 2022
Chief Medical Officer
Sold after exercise
3,122
$15.25
$47.61K
Dipal Doshi
28 Sep 2022
President and CEO
Sell
3,085
$15.23
$47.00K
Nerissa Kreher
27 Sep 2022
Chief Medical Officer
Sold after exercise
2,403
$15.31
$36.79K
Dipal Doshi
27 Sep 2022
President and CEO
Sell
966
$15.82
$15.29K
Dipal Doshi
27 Sep 2022
President and CEO
Sell
3,453
$15.04
$51.93K
Nathan J Dowden
26 Sep 2022
Chief Operating Officer
Sell
215
$16.25
$3.49K
Nathan J Dowden
26 Sep 2022
Chief Operating Officer
Sell
1,329
$15.32
$20.36K
Nerissa Kreher
26 Sep 2022
Chief Medical Officer
Sold after exercise
300
$16.33
$4.90K
Nerissa Kreher
26 Sep 2022
Chief Medical Officer
Sold after exercise
2,768
$15.22
$42.13K
Dipal Doshi
26 Sep 2022
President and CEO
Sell
288
$16.30
$4.70K
Dipal Doshi
26 Sep 2022
President and CEO
Sell
2,795
$15.22
$42.53K
Nathan J Dowden
23 Sep 2022
Chief Operating Officer
Sell
1,018
$15.07
$15.34K
Nerissa Kreher
23 Sep 2022
Chief Medical Officer
Sold after exercise
939
$15.09
$14.17K
Dipal Doshi
23 Sep 2022
President and CEO
Sell
1,023
$15.07
$15.41K
Nathan J Dowden
21 Sep 2022
Chief Operating Officer
Sell
3,275
$15.13
$49.54K
Nerissa Kreher
21 Sep 2022
Chief Medical Officer
Sold after exercise
3,341
$15.08
$50.39K
Dipal Doshi
21 Sep 2022
President and CEO
Sell
3,402
$15.12
$51.43K
Nerissa Kreher
15 Sep 2022
Chief Medical Officer
Sold after exercise
106
$15.01
$1.59K
Nathan J Dowden
15 Sep 2022
Chief Operating Officer
Sell
100
$15.01
$1.50K
Dipal Doshi
15 Sep 2022
President and CEO
Sell
200
$15.04
$3.01K
Nathan J Dowden
9 Sep 2022
Chief Operating Officer
Sell
865
$15.06
$13.03K
Nerissa Kreher
9 Sep 2022
Chief Medical Officer
Sold after exercise
800
$15.07
$12.05K
Dipal Doshi
9 Sep 2022
President and CEO
Sell
688
$15.07
$10.37K
Nathan J Dowden
8 Sep 2022
Chief Operating Officer
Sell
912
$15.15
$13.81K
Nerissa Kreher
8 Sep 2022
Chief Medical Officer
Sold after exercise
1,221
$15.13
$18.48K
Dipal Doshi
8 Sep 2022
President and CEO
Sell
1,100
$15.16
$16.67K
Dipal Doshi
31 Aug 2022
President and CEO
Sell
171
$12.00
$2.05K
Dipal Doshi
30 Aug 2022
President and CEO
Sell
190
$12.00
$2.28K
Dipal Doshi
29 Aug 2022
President and CEO
Sell
25
$14.00
$350.00
Dipal Doshi
29 Aug 2022
President and CEO
Sell
505
$13.51
$6.82K
Dipal Doshi
29 Aug 2022
President and CEO
Sell
1,109
$12.56
$13.93K
Kory James Wentworth
25 Aug 2022
Chief Financial Officer
Sell
1,551
$14.18
$21.99K
Kory James Wentworth
24 Aug 2022
Chief Financial Officer
Sold after exercise
301
$14.23
$4.28K
Kory James Wentworth
24 Aug 2022
Chief Financial Officer
Sold after exercise
2,817
$13.52
$38.09K
Kory James Wentworth
23 Aug 2022
Chief Financial Officer
Sold after exercise
2,909
$13.09
$38.08K
Kory James Wentworth
22 Aug 2022
Chief Financial Officer
Sold after exercise
217
$13.00
$2.82K
Kory James Wentworth
19 Aug 2022
Chief Financial Officer
Sold after exercise
8,529
$13.08
$111.53K
Kory James Wentworth
18 Aug 2022
Chief Financial Officer
Sold after exercise
200
$13.00
$2.60K
Kory James Wentworth
17 Aug 2022
Chief Financial Officer
Sold after exercise
200
$13.07
$2.61K
Kory James Wentworth
16 Aug 2022
Chief Financial Officer
Sold after exercise
200
$13.00
$2.60K
Dipal Doshi
27 Jul 2022
President and CEO
Sell
2,000
$12.00
$24.00K
Dipal Doshi
27 Jun 2022
President and CEO
Sell
4,000
$12.00
$48.00K
Nathan J Dowden
27 Jun 2022
Chief Operating Officer
Sell
7,714
$13.00
$100.28K
Baker Bros. Advisors LP
6 Jun 2022
10% owner
Buy indirect
26,450
$6.42
$169.85K
Showing 250 of 282 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 62
Sales straight out of an exercise 45
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 26,064,466
Sales filed before the plan box existed 55
History held since 1 Nov 2021